Long-term clinical outcomes with <i>Clostridium butyricum</i> MIYAIRI 588 (CBM588) and TOPOSCORE assessment in patients receiving immune checkpoint inhibitor (ICI)-based combinations for metastatic renal cell carcinoma (mRCC).Sumanta Kumar Pal, Miguel Zugman, Xiaochen Li et al.|Journal of Clinical Oncology|2026Cited by 0